📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-01 10:53
712 analysed today
712
Today
133,601
All-time analysed
40,124
Positive
6,284
Negative
79,373
Neutral
7,752
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
8 announcements match the current filters (relevance ≥ 5).
BSE Approves Preferential Issue of 4.24 Lakh Shares at ₹2,341/share to Raise ~₹99.4 Cr
TANFAC Industries has received in-principle approval from BSE Limited for a proposed preferential issue of 4,24,647 equity shares of face value ₹5 each at an issue price of ₹2,341 per share. The issue will raise approximately ₹99.41 crore from promoter and non-promoter investors. This fundraise represents roughly 26.6% of the company's net worth (₹373 crore) and about 1.6% of its market capitalization (₹6,222 crore). The approval was granted via BSE's letter dated August 31, 2026.
Confidence: HIGH
What changedTANFAC received formal in-principle approval from BSE Limited to proceed with its preferential equity allotment.
Why it mattersThe ₹99.41 crore fund infusion strengthens the balance sheet (representing ~26.6% of net worth) and can fund upcoming growth or working capital needs.
Shares to be issued: 4,24,647Issue price: ₹2,341/- per Equity ShareTotal fundraise: ~₹99.41 crFundraise vs Net Worth: ~26.6%
📅 Short termProgresses the preferential placement process towards final allotment and listing of shares.
📈 Long termProvides growth capital to support capacity additions or operational expansion without increasing debt leverage.
⚠ Risk flags
- Equity dilution of ~2.1% based on outstanding share capital
- Issue price (₹2,341) is at a discount to the current market price (₹3,103.2)
Key Highlights
BSE in-principle approval received via letter dated August 31, 2026
4,24,647 equity shares of face value ₹5/- each to be issued on a preferential basis
Issue price fixed at ₹2,341 per equity share, aggregating to ~₹99.41 crore
Allotment to be made to both Promoter and Non-Promoter investors
👀 What to Watch
Track the final allotment date, listing approval for new shares, and details regarding the end-use of proceeds for capex or debt reduction.
Rs 350 Cr Fundraise and Rs 395 Cr HFC-32 Project Progress Highlighted in Q1 FY27 Call
TANFAC reported a 6% YoY revenue growth to Rs 187 Cr in Q1 FY27, while transitioning to a net debt-free status following a Rs 250 Cr QIP and a proposed Rs 100 Cr preferential issue. The company is aggressively expanding into high-value fluorochemicals, with its Rs 395 Cr HFC-32 project (representing ~55% of TTM revenue) on track for Q3 FY27 commissioning. Management highlighted that 65% of the HFC-32 capacity is already secured under long-term agreements. Additionally, the company is ramping up its solar grade DHF business and exploring semiconductor-grade chemicals with 1,000x higher purity requirements.
Confidence: HIGH
What changedThe company has transitioned to a net debt-free balance sheet with Rs 350 Cr in fresh capital and is nearing the completion of a major HFC-32 capacity expansion.
Why it mattersThis shift from commodity chemicals to high-value specialty fluorochemicals (Solar/Semiconductor grade) and refrigerants (HFC-32) is expected to drive margin expansion and revenue growth.
HFC-32 Project Cost: Rs 395 CrHFC-32 vs TTM Revenue: ~55.5%QIP Fundraise: Rs 250 CrHFC-32 Pre-booked Capacity: 65%Q1 FY27 Revenue: Rs 187 CrNet Debt: Rs 0
📅 Short termFocus will be on the 30-45 day pricing cycle to see if higher input costs (sulphur/fuel) are successfully passed through to customers to recover margins.
📈 Long termThe HFC-32 project and potential entry into semiconductor-grade chemicals (1-1.5 year approval cycle) represent a structural transformation of the business model towards high-margin specialty chemicals.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Project execution risk for HFC-32
- Raw material price volatility (Sulphur)
- Long approval cycles for semiconductor products
Key Highlights
Completed Rs 250 Cr QIP and proposed Rs 100 Cr preferential issue to become net debt-free.
Rs 395 Cr HFC-32 project is 80% committed (Rs 315 Cr) and 65% pre-booked by volume.
Q1 FY27 revenue grew 6% YoY to Rs 187 Cr despite higher fuel and sulphur costs.
Solar grade DHF business secured with long-term contracts extending through FY29.
Targeting semiconductor grade DHF with 1,000x higher purity requirements (100 PPT vs 10 PPB).
👀 What to Watch
Monitor the commissioning timeline of the HFC-32 plant by Q3 FY27 and the progress of the NSE listing application to improve liquidity.
TANFAC Industries Approves Preferential Issue of 4.24 Lakh Shares at EGM
TANFAC Industries held an Extra-Ordinary General Meeting (EGM) on July 30, 2026, where shareholders approved a special resolution for a preferential issue of up to 4,24,647 equity shares. At the current market price of ‡2,862.2, this represents a potential capital infusion of approximately ‡121.5 crore, which is roughly 32.5% of the company's current net worth. The meeting also confirmed the appointment of Dr. D. Karthikeyan as a Nominee Director. This move indicates a significant capital-raising exercise, likely aimed at strengthening the balance sheet or funding future growth.
Confidence: HIGH
What changedShareholders have authorized the board to issue new equity shares on a preferential basis, leading to a capital infusion and a minor equity dilution of approximately 2.1%.
Why it mattersThe fundraise is material relative to the company's net worth (‡373 Cr) and provides liquidity for potential expansions or debt management in the commodity chemicals sector where the company maintains a high ROCE of 24%.
Preferential Issue Size: 4,24,647 sharesEstimated Fundraise vs Net Worth: ~32.5%Estimated Equity Dilution: ~2.13%TTM Revenue: ‡711 CrEGM Date: 2026-07-30
📅 Short termThe stock may see positive sentiment due to the successful approval of the fundraise, though focus will remain on the final issue price.
📈 Long termThe capital infusion supports long-term growth capacity, though investors should monitor if the dilution is offset by improved earnings from the deployed capital.
⚠ Risk flags
- Equity dilution for existing shareholders
- Specific use of proceeds not detailed in the EGM summary
Key Highlights
Approval for issuance of up to 4,24,647 equity shares on a preferential basis via special resolution.
Potential fundraise value estimated at ‡121.5 crore based on current market price, representing ~17% of TTM revenue.
Appointment of Dr. D. Karthikeyan (DIN: 02259481) as a Nominee Director approved by ordinary resolution.
EGM conducted via video conferencing with 70 members in attendance.
Remote e-voting concluded on July 29, 2026, with results to be declared within prescribed timelines.
👀 What to Watch
Watch for the official disclosure of the allotment price and the identity of the allottees to gauge strategic interest. Monitor subsequent filings for the specific utilization plan of the raised capital.
₹390 Cr HFC-32 Project on Track; TANFAC Q1 Revenue up 6.3% to ₹187 Cr
TANFAC reported Q1 FY27 revenue of ₹187.2 cr, a 6.3% YoY increase, though PAT declined to ₹16.8 cr due to higher sulphur prices and geopolitical disruptions. The company successfully raised ₹250 cr via QIP in June 2026 and is planning a ₹100 cr preferential issue, making the balance sheet net debt-free. The primary focus is the ₹390 cr HFC-32 refrigerant gas project (20,000 MTPA), which is on track for commissioning by Q3 FY27. Crucially, the company has secured long-term supply contracts worth ~₹649 cr per annum starting January 2027, nearly matching its current annual revenue.
Confidence: HIGH
What changedTANFAC has transitioned to a net debt-free balance sheet following a major fundraise and is nearing the completion of its largest-ever downstream expansion into refrigerant gases.
Why it mattersThe HFC-32 project and associated long-term contracts could potentially double the company's revenue base and shift its profile toward high-value specialized fluorochemicals.
HFC-32 Project Cost: ₹390 crProject Cost vs TTM Revenue: 54.8%QIP Fundraise: ₹250 crAnnual Contract Value (from Jan 2027): ₹649 crQ1 FY27 Revenue: ₹187.2 crHFC-32 Capacity: 20,000 MTPA
📅 Short termThe stock may see positive sentiment from the debt-free status and project progress, though margin pressure from sulphur prices remains a near-term monitorable.
📈 Long termStructural transformation into a downstream fluorochemical leader with secured off-take agreements suggests significant growth potential over the next 2-3 years.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for the HFC-32 project commissioning
- Volatility in raw material (sulphur) prices
- Geopolitical disruptions in West Asia affecting supply chains
Key Highlights
₹390 cr investment for 20,000 MTPA HFC-32 project, representing ~55% of TTM revenue
₹250 cr raised through QIP in June 2026, transforming the company to net debt-free status
Secured long-term supply contracts totaling ~₹649 cr per annum starting Jan 2027
Q1 FY27 revenue grew 6.3% YoY to ₹187.2 cr, driven by Solar Grade DHF demand
EBITDA margin compressed to 15.3% from 16.5% YoY due to elevated sulphur and fuel costs
👀 What to Watch
Monitor the commissioning of the HFC-32 project in Q3 FY27 and the subsequent ramp-up of the ₹649 cr/year supply contracts starting Jan 2027.
₹187 Cr Q1 Revenue; ₹390 Cr HFC-32 Project on Track for Q3 FY27 Commissioning
TANFAC Industries reported a 6.3% YoY revenue growth to ₹187.2 Cr for Q1 FY27, though PAT declined 13.4% to ₹16.8 Cr due to margin pressure from higher Sulphur and fuel costs. The company has successfully transformed its balance sheet to become net debt-free following a ₹250 Cr QIP and a proposed ₹100 Cr preferential issue. The primary growth driver is the ₹390 Cr HFC-32 refrigerant gas project (20,000 MTPA), which is equivalent to ~55% of TTM revenue and remains on track for commissioning by Q3 FY27.
Confidence: HIGH
What changedTANFAC has moved to a net debt-free status and secured full funding for its major HFC-32 expansion project while facing temporary margin headwinds from geopolitical disruptions.
Why it mattersThe shift into HFC-32 refrigerant gas represents a significant downstream integration that could diversify revenue streams and improve long-term profitability beyond commodity hydrofluoric acid.
Q1 Revenue: ₹187.2 CrHFC-32 Project Investment: ₹390 CrProject Value vs TTM Revenue: 54.8%QIP Fundraise: ₹250 CrEBITDA Margin: 15.3%HFC-32 Capacity: 20,000 MTPA
📅 Short termThe stock may see neutral to slightly cautious sentiment due to the YoY decline in PAT and margin compression, despite the positive long-term expansion updates.
📈 Long termThe commissioning of the HFC-32 project in late FY27 is a structural pivot that could significantly scale the business and re-rate the company as a specialized fluorochemical player.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical disruptions in West Asia affecting fuel costs
- Volatility in raw material (Sulphur) prices
- Execution risk for the large-scale HFC-32 project
Key Highlights
Revenue increased 6.3% YoY to ₹187.2 Cr, supported by healthy demand for Solar Grade DHF.
Operating EBITDA margin contracted to 15.3% from 16.5% YoY due to elevated Sulphur prices and fuel costs.
Successfully raised ₹250 Cr through a QIP and proposed an additional ₹100 Cr preferential issue.
The ₹390 Cr HFC-32 project (20,000 MTPA capacity) is scheduled for commissioning by the end of Q3 FY27.
Company is now net debt-free, providing financial flexibility for downstream fluorinated chemical expansions.
👀 What to Watch
Investors should monitor the execution and commissioning timeline of the HFC-32 project in Q3 FY27 and the company's ability to pass through raw material costs, which typically follows a 30-45 day cycle.
₹99.41 Cr Preferential Issue to Promoter and Others at ₹2,341 Per Share
TANFAC Industries has called an Extra-Ordinary General Meeting (EGM) on July 30, 2026, to approve a preferential issue of 4,24,647 equity shares. The issue is priced at ₹2,341 per share, aiming to raise approximately ₹99.41 crore. The promoter, Anupam Rasayan India Limited, will subscribe to 2,60,065 shares (approx. 61% of the issue), while the remaining 1,64,582 shares are allocated to three non-promoter entities. Additionally, the company is seeking approval for the appointment of Dr. D. Karthikeyan (IAS) as a Nominee Director.
Confidence: HIGH
What changedThe company is initiating a significant equity fundraise through a preferential allotment to its promoter and select non-promoter investors.
Why it mattersThe ₹99.41 crore capital infusion strengthens the company's capital base and demonstrates strong financial commitment from the promoter, Anupam Rasayan. The pricing at ₹2,341 provides a clear valuation benchmark for the market.
Issue Price: ₹2,341 per shareTotal Fundraise: ₹99.41 crorePromoter Subscription: 2,60,065 sharesNon-Promoter Subscription: 1,64,582 sharesRelevant Date: June 30, 2026
📅 Short termThe stock price may align with the preferential issue price of ₹2,341 in the coming weeks as the market processes the promoter's commitment.
📈 Long termThe infusion of nearly ₹100 crore provides the company with significant liquidity to fund future expansions or operational requirements, potentially improving the long-term growth trajectory.
⚠ Risk flags
- Equity dilution for existing minority shareholders
- Specific end-use of funds not detailed in the EGM notice
Key Highlights
Preferential issue of up to 4,24,647 equity shares at a price of ₹2,341 per share
Total aggregate fundraise amount of ₹99,40,98,627 (~₹99.41 crore)
Promoter Anupam Rasayan India Limited to subscribe to 2,60,065 shares
Relevant date for pricing determination set as June 30, 2026
EGM scheduled for July 30, 2026, with a voting cut-off date of July 23, 2026
👀 What to Watch
Monitor the outcome of the EGM on July 30, 2026, and subsequent allotment within the 15-day regulatory window. Investors should look for further disclosures regarding the specific utilization of these funds for growth or debt reduction.
₹99.41 Cr Fundraise: TANFAC Industries Reduces Preferential Issue Size by 43%
TANFAC Industries has revised its proposed preferential issue size downward to ₹99.41 crore from the initially approved ₹173.49 crore. The reduction follows a revised expression of interest from its promoter, Anupam Rasayan India Limited, which will now subscribe to 2,60,065 shares. The issue is priced at ₹2,341 per share, representing a significant premium over the ₹5 face value. Post-allotment, the promoter's stake will increase slightly from 24.26% to 24.99%.
Confidence: HIGH
What changedThe company scaled back its planned capital raise by approximately ₹74 crore due to a revised commitment from its promoter.
Why it mattersWhile the company is still raising nearly ₹100 crore in growth capital, the reduction in the issue size suggests a change in immediate capital requirements or a strategic decision by the promoter to limit dilution/investment at this stage.
Revised Issue Size: ₹99,40,98,627Original Issue Size: ₹1,73,48,72,962Issue Price per Share: ₹2,341.00Total Shares to be Issued: 4,24,647Promoter Post-Issue Stake: 24.99%
📅 Short termThe market may react to the reduction in the fundraise size, though the fixed price of ₹2,341 provides a clear valuation floor for the transaction.
📈 Long termThe capital infusion will strengthen the balance sheet, though the impact is lower than the initial ₹173 crore plan; long-term value depends on the deployment of these funds into high-margin chemical projects.
⚠ Risk flags
- Reduction in promoter commitment compared to initial board approval
- Pending shareholder and regulatory approvals
Key Highlights
Issue size reduced from ₹173.49 crore to ₹99.41 crore within two days of initial board approval.
Preferential allotment of 4,24,647 equity shares priced at ₹2,341.00 per share.
Promoter Anupam Rasayan India Limited to subscribe to 2,60,065 shares, the largest portion of the issue.
Three non-promoter investors (Alrox Enterprises, Vivek Jain, and Tatvam Trade) to subscribe to 1,64,582 shares.
Promoter post-issue shareholding capped at 24.99% to remain below the 25% takeover code threshold.
👀 What to Watch
Investors should monitor the upcoming shareholder meeting for approval and watch for disclosures regarding the specific utilization of the ₹99.41 crore proceeds.
₹423.5 Cr Fundraise: TANFAC Completes QIP and Announces Preferential Issue for Expansion
TANFAC Industries has successfully raised ~₹250 crore through a Qualified Institutional Placement (QIP) completed on June 25, 2026. The company has further approved a preferential issue of ~₹173.5 crore at ₹2,341 per share, with the promoter Anupam Rasayan contributing ₹135 crore. The total capital raise of ₹423.5 crore will be utilized to enter the R-32 refrigerant gas segment and expand value-added fluorochemical products. This fundraise follows a ₹500 crore enabling resolution approved by shareholders in February 2026.
Confidence: HIGH
What changedThe company has moved from a planned fundraise to executing a two-tranche capital infusion involving both institutional investors and promoters.
Why it mattersThis capital infusion significantly strengthens the balance sheet and provides the necessary funding for a major strategic pivot into the R-32 refrigerant gas market, a high-growth segment in fluorochemicals.
QIP Amount Raised: ₹250 crorePreferential Issue Amount: ₹173.5 crorePreferential Issue Price: ₹2,341 per sharePromoter Contribution (Preferential): ₹135 croreTotal Capital Raise: ₹423.5 crore
📅 Short termThe participation of marquee investors like the Shanghvi Family Office and the promoter's commitment at ₹2,341 per share is likely to provide a positive sentiment floor for the stock.
📈 Long termEntry into the R-32 refrigerant gas segment represents a structural expansion that could diversify revenue and improve long-term margins if execution is successful.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk in the new R-32 refrigerant segment
- Regulatory and shareholder approval for the preferential issue
Key Highlights
Raised ~₹250 crore via QIP of 12,58,918 equity shares completed on June 25, 2026
Proposed preferential issue of 7,41,082 shares at ₹2,341 per share to raise ~₹173.5 crore
Promoter Anupam Rasayan to invest ₹135 crore in the preferential issue
Total aggregate capital raise reaches ~₹423.5 crore for strategic growth initiatives
Funds earmarked for entry into the R-32 refrigerant gas segment and value-added fluorochemicals
👀 What to Watch
Investors should monitor the timeline for shareholder approval of the preferential issue and subsequent project updates regarding the R-32 refrigerant gas facility setup.
